Gefitinib-sensitizing mutations in esophageal carcinoma

被引：40

作者：

Guo, MZ ^{[1
]}

Liu, S

Lu, FM

机构：

[1] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA

[2] Peking Univ, Hlth Sci Ctr, Beijing 100083, Peoples R China

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 354卷 / 20期

关键词：

D O I：

10.1056/NEJMc052698

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2193 / 2194

页数：2

共 5 条

[1] Distinctive activation patterns in constitutively active and gefitinib-sensitive EGFR mutants [J].

Chen, YR ;

Fu, YN ;

Lin, CH ;

Yang, ST ;

Hu, SF ;

Chen, YT ;

Tsai, SF ;

Huang, SF .

ONCOGENE, 2006, 25 (08) :1205-1215

[2] Lack of mutations in EGFR in gastroenteropancreatic neuroendocrine tumors [J].

Gilbert, JA ;

Lloyd, RV ;

Ames, MM .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02) :209-210

[3] Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib [J].

Lynch, TJ ;

Bell, DW ;

Sordella, R ;

Gurubhagavatula, S ;

Okimoto, RA ;

Brannigan, BW ;

Harris, PL ;

Haserlat, SM ;

Supko, JG ;

Haluska, FG ;

Louis, DN ;

Christiani, DC ;

Settleman, J ;

Haber, DA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2129-2139

[4] Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in Chinese patients with non-small cell lung cancer [J].

Mu, XL ;

Li, LY ;

Zhang, XT ;

Wang, MZ ;

Feng, RE ;

Cui, QC ;

Zhou, HS ;

Guo, BQ .

CLINICAL CANCER RESEARCH, 2005, 11 (12) :4289-4294

[5] EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy [J].

Paez, JG ;

Jänne, PA ;

Lee, JC ;

Tracy, S ;

Greulich, H ;

Gabriel, S ;

Herman, P ;

Kaye, FJ ;

Lindeman, N ;

Boggon, TJ ;

Naoki, K ;

Sasaki, H ;

Fujii, Y ;

Eck, MJ ;

Sellers, WR ;

Johnson, BE ;

Meyerson, M .

SCIENCE, 2004, 304 (5676) :1497-1500

← 1 →